- Home
- XLO vs FTHM Comparison
XLO vs FTHM Comparison
Compare XLO & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XLO | FTHM |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.8M | 37.9M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XLO | FTHM |
|---|---|---|
| Price | $0.65 | $1.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.00 | ★ $2.50 |
| AVG Volume (30 Days) | ★ 528.0K | 115.2K |
| Earning Date | 11-13-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $31,804,000.00 | ★ $421,612,000.00 |
| Revenue This Year | $589.60 | $30.07 |
| Revenue Next Year | $38.00 | $14.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 588.40 | 32.78 |
| 52 Week Low | $0.62 | $0.65 |
| 52 Week High | $1.70 | $3.37 |
Technical Indicators
Market Signals| Indicator | XLO | FTHM |
|---|---|---|
| Relative Strength Index (RSI) | 32.82 | 39.89 |
| Support Level | $0.68 | $1.16 |
| Resistance Level | $0.73 | $1.27 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 10.24 | 4.55 |
Price Performance
Historical ComparisonAbout XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.